Ocular delivery of proteins and peptides: Challenges and novel formulation approaches.
The impact of proteins and peptides on the treatment of various conditions including ocular diseases over the past few decades has been advanced by substantial breakthroughs in structural biochemistry, genetic engineering, formulation and delivery approaches. Formulation and delivery of proteins and peptides, such as monoclonal antibodies, aptamers, recombinant proteins and peptides to ocular tissues poses significant challenges owing to their large size, poor permeation and susceptibility to degradation. A wide range of advanced drug delivery systems including polymeric controlled release systems, cell-based delivery and nanowafers are being exploited to overcome the challenges of frequent administration to ocular tissues. The next generation systems integrated with new delivery technologies are anticipated to generate improved efficacy and safety through the expansion of the therapeutic target space. This review will highlight recent advances in formulation and delivery strategies of protein and peptide based biopharmaceuticals. We will also describe the current state of proteins and peptides based ocular therapy and future therapeutic opportunities.
['Mandal|Abhirup|A|', 'Pal|Dhananjay|D|', 'Agrahari|Vibhuti|V|', 'Trinh|Hoang My|HM|', 'Joseph|Mary|M|', 'Mitra|Ashim K|AK|']
D016503:Drug Delivery Systems D005128:Eye Diseases D005818:Genetic Engineering D006801:Humans D010455:Peptides D011506:Proteins
Drug delivery Controlled release Targeting Biopharmaceuticals AMD Barriers Biologics Eye Macromolecules